1 / 4

Genitourinary Drugs Market

Genitourinary Drugs Market

farazp70
Download Presentation

Genitourinary Drugs Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research Genitourinary Drugs Market Size, Share, Growth, Industry Analysis Report and Forecast to 2025 Request https://www.omrglobal.com/request-sample/genitourinary-drugs-market a free sample of our report on Market: Genitourinary Drugs ------------------------------------------------------------------------------------ Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404

  2. The global genitourinary drug market is expected to show a moderate growth rate during the forecast period. A genitourinary drug refers to pharmaceuticals that used to treat diseases of the genital and urinary tract such as ureters, bladder, kidneys, and urethra among others. Genitourinary problems including neurogenic dysfunction, prostatism, urinary tract infections, and prostate cancer, are the common disorders in elderly people. The genitourinary tract is the medicines that are used to treat conditions of the reproductive organs and urinary tract. Urinary is the system that is responsible for the removal of nitrogenous waste products of metabolism from the bloodstream and disposal of concentrate waste. Genito is a genital organ and reproductive system that is responsible for the production of succeeding generations. Get Sample Copy of Genitourinary Drugs Market at:https://www.omrglobal.com/request- sample/genitourinary-drugs-market Major players of the genitourinary drugs market include Abbott Laboratories, Bayer AG, Eli Lilly& Co., Bristol-Myers Squibb Co., Astellas Pharma US, Inc., AstraZeneca PLC, GlaxoSmithKline PLC, Merck & Co., Inc., Pfizer, Inc., Johnson & Johnson Service, Inc, Hoffman- La Roche AG, and Melinta Therapeutics Inc. The genitourinary system is affected by congenital abnormalities, infection, inflammation, and diseases of kidneys. Moreover, the rise in the incidence of urinary tract infections and the demand for drugs increases that results in driving the global genitourinary drugs market during the forecast period. Additionally, the launch of combination, drugs, development and approval of new drugs that are more efficient and growing aging population are anticipated to propel the growth of the genitourinary drugs industry. The FDA (Food and Drug Administration) approval of various drugs from 2017 to 2019 includes Avelumab, Pembrolizumab, Erdafitinib (ASG- 22ME), Enzalutamide and Apalutamide. A full report of Global Genitourinary Drugs Market is available at: https://www.omrglobal.com/industry-reports/genitourinary-drugs-market Additionally, the demand for the drugs is growing along with the incidence of urinary tract boost the growth of the urinary tract infection across the globe. The urinary tract infection is the second most common infection in the aging population. The diagnosis and treatment of UTI are more complicated in elderly patients than in younger ones owing to factors such as spinal cord injuries, diabetes, old age and prostate diseases in men. For instance, in August 2017, Vabomere is an FDA approved drug for adults. It is an antibacterial drug that is used for the treatment of complicated urinary tract infection and pyelonephritis is a type of kidney infection caused by specific bacteria. Vobomere is consisting of vaborbactam and meropenem. In December 2017, the FDA approved the review of new drug applications submitted by Achaogen for plazomicin to treat the urinary tract including bloodstream infections. Global Genitourinary Drugs Market- Segmentation By-Products

  3. Hormonal Therapy Impotence Agents Uterine Relaxants Urinary Antispasmodics Urinary pH Modifiers Uterine Stimulants Miscellaneous Genitourinary Tract Agents By Disease Erectile Dysfunction Urinary Tract Infections Urinary Incontinence Glomerulonephritis Chronic Renal Failure Genitourinary Cancers Other Diseases Global Genitourinary Drugs Market – Segment by Region North America US Canada Europe Germany UK France Spain Italy Rest of Europe Asia-Pacific China Japan India Rest of Asia-Pacific

  4. Rest of the World Latin America Middle East Africa For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/genitourinary-drugs-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. For More Information, Visithttps://www.omrglobal.com/ Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404

More Related